Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

Staiger, Annette M.; Ziepert, Marita; Horn, Heike; Scott, David W.; Barth, Thomas F. E.; Bernd, Heinz-Wolfram; Feller, Alfred C.; Klapper, Wolfram; Szczepanowski, Monika; Hummel, Michael; Stein, Harald; Lenze, Dido; Hansmann, Martin-Leo; Hartmann, Sylvia; Moeller, Peter; Cogliatti, Sergio; Lenz, Georg; Truemper, Lorenz; Loeffler, Markus; Schmitz, Norbert; Pfreundschuh, Michael; Rosenwald, Andreas; Ott, German

Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

Author:

Staiger, Annette M.; Ziepert, Marita; Horn, Heike; Scott, David W.; Barth, Thomas F. E.; Bernd, Heinz-Wolfram; Feller, Alfred C.; Klapper, Wolfram; Szczepanowski, Monika; Hummel, Michael; Stein, Harald; Lenze, Dido; Hansmann, Martin-Leo; Hartmann, Sylvia; Moeller, Peter; Cogliatti, Sergio; Lenz, Georg; Truemper, Lorenz; Loeffler, Markus; Schmitz, Norbert; Pfreundschuh, Michael; Rosenwald, Andreas; Ott, German

Tübinger Autor(en):

Staiger, Annette M.
Horn, Heike

Published in:

Journal of Clinical Oncology (2017), Bd. 35, H. 22, S. 2515-

Verlagsangabe:

Amer Soc Clinical Oncology

Language:

English

Full text:

http://dx.doi.org/10.1200/JCO.2016.70.3660

ISSN:

1527-7755